Detalhe da pesquisa
1.
Adverse event burden in older patients with CLL receiving bendamustine plus rituximab or ibrutinib regimens: Alliance A041202.
Leukemia
; 35(10): 2854-2861, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34274940
2.
Randomized, Multicenter, Placebo-Controlled Clinical Trial of Duloxetine Versus Placebo for Aromatase Inhibitor-Associated Arthralgias in Early-Stage Breast Cancer: SWOG S1202.
J Clin Oncol
; 36(4): 326-332, 2018 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29136387
3.
Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II to III triple-negative breast cancer: CALGB 40603 (Alliance).
J Clin Oncol
; 33(1): 13-21, 2015 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25092775